Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development

Kazunari Akagi, Yoichi Ikeda, Yasushi Sumiyoshi, Yasue Kimura, Junko Kinoshita, Mitsuhiro Miyazaki, Toru Abe

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Background. The expression of panendothelial markers (eg, CD34, CD31, and factor VIII) is not always observed in angiogenic vessels, and such markers are not useful for measuring angiogenesis. In contrast, CD105 is preferentially expressed in angiogenic vessels and thus may be valuable for measuring angiogenesis. We hypothesized that microvessel quantification by means of CD105 might be useful for measuring angiogenesis in the colorectal adenoma-carcinoma sequence. Methods. We immunohistochemically investigated 54 cases of colorectal adenomas and 20 cases of carcinomas using monoclonal antibodies CD34 and CD105, and microvessel density (MVD) was counted at ×200 magnification. Results. Microvessels positive for CD34 were distributed almost uniformly in adenomas. In contrast, microvessels positive for CD105 were preferentially observed in the surface area of adenomas. In carcinomas, CD34 stained only a proportion of blood vessels that were positive for CD105. No significant difference of MVD for CD34 was observed in the colorectal adenoma-carcinoma sequence. In contrast, an increment of MVD for CD105 from low-grade to high-grade dysplasia (P < .0001) and that from high-grade dysplasia to carcinomas (P < .05) was statistically significant. Conclusions. Assessing neovascularization with CD105 in the process of colorectal cancer development may thus be a valuable marker for predicting the risk of colorectal cancer development.

Original languageEnglish
Pages (from-to)S109-S113
JournalSurgery
Volume131
Issue number1 SUPPL.
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Microvessels
Colorectal Neoplasms
Adenoma
Carcinoma
Factor VIII
Blood Vessels
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Akagi, K., Ikeda, Y., Sumiyoshi, Y., Kimura, Y., Kinoshita, J., Miyazaki, M., & Abe, T. (2002). Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development. Surgery, 131(1 SUPPL.), S109-S113. https://doi.org/10.1067/msy.2002.119361

Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development. / Akagi, Kazunari; Ikeda, Yoichi; Sumiyoshi, Yasushi; Kimura, Yasue; Kinoshita, Junko; Miyazaki, Mitsuhiro; Abe, Toru.

In: Surgery, Vol. 131, No. 1 SUPPL., 01.01.2002, p. S109-S113.

Research output: Contribution to journalArticle

Akagi, K, Ikeda, Y, Sumiyoshi, Y, Kimura, Y, Kinoshita, J, Miyazaki, M & Abe, T 2002, 'Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development', Surgery, vol. 131, no. 1 SUPPL., pp. S109-S113. https://doi.org/10.1067/msy.2002.119361
Akagi, Kazunari ; Ikeda, Yoichi ; Sumiyoshi, Yasushi ; Kimura, Yasue ; Kinoshita, Junko ; Miyazaki, Mitsuhiro ; Abe, Toru. / Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development. In: Surgery. 2002 ; Vol. 131, No. 1 SUPPL. pp. S109-S113.
@article{ea34710713a74bf4a0d890e9cee2182e,
title = "Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development",
abstract = "Background. The expression of panendothelial markers (eg, CD34, CD31, and factor VIII) is not always observed in angiogenic vessels, and such markers are not useful for measuring angiogenesis. In contrast, CD105 is preferentially expressed in angiogenic vessels and thus may be valuable for measuring angiogenesis. We hypothesized that microvessel quantification by means of CD105 might be useful for measuring angiogenesis in the colorectal adenoma-carcinoma sequence. Methods. We immunohistochemically investigated 54 cases of colorectal adenomas and 20 cases of carcinomas using monoclonal antibodies CD34 and CD105, and microvessel density (MVD) was counted at ×200 magnification. Results. Microvessels positive for CD34 were distributed almost uniformly in adenomas. In contrast, microvessels positive for CD105 were preferentially observed in the surface area of adenomas. In carcinomas, CD34 stained only a proportion of blood vessels that were positive for CD105. No significant difference of MVD for CD34 was observed in the colorectal adenoma-carcinoma sequence. In contrast, an increment of MVD for CD105 from low-grade to high-grade dysplasia (P < .0001) and that from high-grade dysplasia to carcinomas (P < .05) was statistically significant. Conclusions. Assessing neovascularization with CD105 in the process of colorectal cancer development may thus be a valuable marker for predicting the risk of colorectal cancer development.",
author = "Kazunari Akagi and Yoichi Ikeda and Yasushi Sumiyoshi and Yasue Kimura and Junko Kinoshita and Mitsuhiro Miyazaki and Toru Abe",
year = "2002",
month = "1",
day = "1",
doi = "10.1067/msy.2002.119361",
language = "English",
volume = "131",
pages = "S109--S113",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Estimation of angiogenesis with anti-CD 105 immunostaining in the process of colorectal cancer development

AU - Akagi, Kazunari

AU - Ikeda, Yoichi

AU - Sumiyoshi, Yasushi

AU - Kimura, Yasue

AU - Kinoshita, Junko

AU - Miyazaki, Mitsuhiro

AU - Abe, Toru

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background. The expression of panendothelial markers (eg, CD34, CD31, and factor VIII) is not always observed in angiogenic vessels, and such markers are not useful for measuring angiogenesis. In contrast, CD105 is preferentially expressed in angiogenic vessels and thus may be valuable for measuring angiogenesis. We hypothesized that microvessel quantification by means of CD105 might be useful for measuring angiogenesis in the colorectal adenoma-carcinoma sequence. Methods. We immunohistochemically investigated 54 cases of colorectal adenomas and 20 cases of carcinomas using monoclonal antibodies CD34 and CD105, and microvessel density (MVD) was counted at ×200 magnification. Results. Microvessels positive for CD34 were distributed almost uniformly in adenomas. In contrast, microvessels positive for CD105 were preferentially observed in the surface area of adenomas. In carcinomas, CD34 stained only a proportion of blood vessels that were positive for CD105. No significant difference of MVD for CD34 was observed in the colorectal adenoma-carcinoma sequence. In contrast, an increment of MVD for CD105 from low-grade to high-grade dysplasia (P < .0001) and that from high-grade dysplasia to carcinomas (P < .05) was statistically significant. Conclusions. Assessing neovascularization with CD105 in the process of colorectal cancer development may thus be a valuable marker for predicting the risk of colorectal cancer development.

AB - Background. The expression of panendothelial markers (eg, CD34, CD31, and factor VIII) is not always observed in angiogenic vessels, and such markers are not useful for measuring angiogenesis. In contrast, CD105 is preferentially expressed in angiogenic vessels and thus may be valuable for measuring angiogenesis. We hypothesized that microvessel quantification by means of CD105 might be useful for measuring angiogenesis in the colorectal adenoma-carcinoma sequence. Methods. We immunohistochemically investigated 54 cases of colorectal adenomas and 20 cases of carcinomas using monoclonal antibodies CD34 and CD105, and microvessel density (MVD) was counted at ×200 magnification. Results. Microvessels positive for CD34 were distributed almost uniformly in adenomas. In contrast, microvessels positive for CD105 were preferentially observed in the surface area of adenomas. In carcinomas, CD34 stained only a proportion of blood vessels that were positive for CD105. No significant difference of MVD for CD34 was observed in the colorectal adenoma-carcinoma sequence. In contrast, an increment of MVD for CD105 from low-grade to high-grade dysplasia (P < .0001) and that from high-grade dysplasia to carcinomas (P < .05) was statistically significant. Conclusions. Assessing neovascularization with CD105 in the process of colorectal cancer development may thus be a valuable marker for predicting the risk of colorectal cancer development.

UR - http://www.scopus.com/inward/record.url?scp=0036163111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036163111&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.119361

DO - 10.1067/msy.2002.119361

M3 - Article

C2 - 11821796

AN - SCOPUS:0036163111

VL - 131

SP - S109-S113

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 1 SUPPL.

ER -